Apollo Endosurgery Inc (APEN) Major Shareholder Stonepine Capital, L.P. Purchases 5,163 Shares of Stock

Apollo Endosurgery Inc (NASDAQ:APEN) major shareholder Stonepine Capital, L.P. acquired 5,163 shares of Apollo Endosurgery stock in a transaction on Saturday, December 29th. The shares were purchased at an average cost of $5.56 per share, with a total value of $28,706.28. Following the completion of the purchase, the insider now directly owns 2,560,314 shares of the company’s stock, valued at approximately $14,235,345.84. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Stonepine Capital, L.P. also recently made the following trade(s):

  • On Wednesday, January 3rd, Stonepine Capital, L.P. purchased 22,845 shares of Apollo Endosurgery stock. The stock was bought at an average cost of $5.71 per share, with a total value of $130,444.95.
  • On Tuesday, December 26th, Stonepine Capital, L.P. purchased 5,287 shares of Apollo Endosurgery stock. The stock was bought at an average cost of $5.00 per share, with a total value of $26,435.00.
  • On Wednesday, December 20th, Stonepine Capital, L.P. purchased 45,434 shares of Apollo Endosurgery stock. The stock was bought at an average cost of $4.50 per share, with a total value of $204,453.00.
  • On Friday, December 22nd, Stonepine Capital, L.P. purchased 185,157 shares of Apollo Endosurgery stock. The stock was bought at an average cost of $4.85 per share, with a total value of $898,011.45.

Apollo Endosurgery Inc (APEN) traded down $0.07 during midday trading on Thursday, hitting $5.82. 66,700 shares of the stock were exchanged, compared to its average volume of 76,200. The company has a quick ratio of 2.00, a current ratio of 2.54 and a debt-to-equity ratio of 0.58. The stock has a market capitalization of $102.53, a price-to-earnings ratio of -0.27 and a beta of 0.44. Apollo Endosurgery Inc has a 1-year low of $3.55 and a 1-year high of $19.95.

A number of analysts have recently issued reports on APEN shares. Northland Securities reissued a “buy” rating and issued a $12.00 price target on shares of Apollo Endosurgery in a research report on Monday, December 4th. Zacks Investment Research raised shares of Apollo Endosurgery from a “hold” rating to a “buy” rating and set a $4.75 price target for the company in a research report on Thursday, November 2nd. Roth Capital set a $10.00 price target on shares of Apollo Endosurgery and gave the stock a “buy” rating in a research report on Thursday. Finally, ValuEngine raised shares of Apollo Endosurgery from a “strong sell” rating to a “sell” rating in a research report on Wednesday. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $9.44.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Stonepine Capital Management LLC bought a new position in Apollo Endosurgery during the third quarter valued at approximately $11,067,000. King Luther Capital Management Corp bought a new position in Apollo Endosurgery during the third quarter valued at approximately $2,567,000. Russell Investments Group Ltd. bought a new position in Apollo Endosurgery during the third quarter valued at approximately $1,288,000. Woodmont Investment Counsel LLC bought a new position in Apollo Endosurgery during the third quarter valued at approximately $220,000. Finally, JPMorgan Chase & Co. bought a new position in Apollo Endosurgery during the third quarter valued at approximately $119,000. 23.67% of the stock is owned by institutional investors and hedge funds.

WARNING: “Apollo Endosurgery Inc (APEN) Major Shareholder Stonepine Capital, L.P. Purchases 5,163 Shares of Stock” was first reported by Transcript Daily and is the property of of Transcript Daily. If you are reading this article on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this article can be viewed at https://transcriptdaily.com/2018/01/04/apollo-endosurgery-inc-apen-major-shareholder-stonepine-capital-l-p-purchases-5163-shares-of-stock.html.

About Apollo Endosurgery

Apollo Endosurgery, Inc, formerly Lpath, Inc, is a medical device company. The Company is focused on less invasive therapies for the treatment of obesity, as well as other gastrointestinal disorders. The Company’s device-based therapies are an alternative to invasive surgical procedures. The Company offers products in over 80 countries.

Insider Buying and Selling by Quarter for Apollo Endosurgery (NASDAQ:APEN)

Receive News & Ratings for Apollo Endosurgery Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Endosurgery and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply